HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,410.00
+10.00 (0.23%)
At close: Dec 5, 2025

HYUNDAI BIOLAND Statistics

Total Valuation

HYUNDAI BIOLAND has a market cap or net worth of KRW 132.30 billion. The enterprise value is 121.02 billion.

Market Cap 132.30B
Enterprise Value 121.02B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date Feb 4, 2026
Ex-Dividend Date Dec 27, 2024

Share Statistics

HYUNDAI BIOLAND has 30.00 million shares outstanding. The number of shares has increased by 0.36% in one year.

Current Share Class 30.00M
Shares Outstanding 30.00M
Shares Change (YoY) +0.36%
Shares Change (QoQ) -0.98%
Owned by Insiders (%) n/a
Owned by Institutions (%) 0.80%
Float 19.50M

Valuation Ratios

The trailing PE ratio is 10.68 and the forward PE ratio is 7.23.

PE Ratio 10.68
Forward PE 7.23
PS Ratio 1.02
PB Ratio 0.96
P/TBV Ratio 0.98
P/FCF Ratio 8.39
P/OCF Ratio 6.57
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.78, with an EV/FCF ratio of 7.68.

EV / Earnings -38.55
EV / Sales 0.93
EV / EBITDA 5.78
EV / EBIT 7.75
EV / FCF 7.68

Financial Position

The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.08.

Current Ratio 3.51
Quick Ratio 1.60
Debt / Equity 0.08
Debt / EBITDA 0.50
Debt / FCF 0.67
Interest Coverage 31.77

Financial Efficiency

Return on equity (ROE) is 8.79% and return on invested capital (ROIC) is 5.96%.

Return on Equity (ROE) 8.79%
Return on Assets (ROA) 5.44%
Return on Invested Capital (ROIC) 5.96%
Return on Capital Employed (ROCE) 11.15%
Revenue Per Employee 380.29M
Profits Per Employee -9.21M
Employee Count 341
Asset Turnover 0.72
Inventory Turnover 1.52

Taxes

In the past 12 months, HYUNDAI BIOLAND has paid 1.84 billion in taxes.

Income Tax 1.84B
Effective Tax Rate 12.86%

Stock Price Statistics

The stock price has increased by +4.13% in the last 52 weeks. The beta is 0.83, so HYUNDAI BIOLAND's price volatility has been lower than the market average.

Beta (5Y) 0.83
52-Week Price Change +4.13%
50-Day Moving Average 4,536.10
200-Day Moving Average 4,630.40
Relative Strength Index (RSI) 50.05
Average Volume (20 Days) 60,223

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HYUNDAI BIOLAND had revenue of KRW 129.68 billion and -3.14 billion in losses. Loss per share was -104.24.

Revenue 129.68B
Gross Profit 56.06B
Operating Income 15.61B
Pretax Income 14.28B
Net Income -3.14B
EBITDA 20.95B
EBIT 15.61B
Loss Per Share -104.24
Full Income Statement

Balance Sheet

The company has 21.83 billion in cash and 10.55 billion in debt, giving a net cash position of 11.28 billion or 376.11 per share.

Cash & Cash Equivalents 21.83B
Total Debt 10.55B
Net Cash 11.28B
Net Cash Per Share 376.11
Equity (Book Value) 137.95B
Book Value Per Share 4,584.00
Working Capital 64.87B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 20.13 billion and capital expenditures -4.37 billion, giving a free cash flow of 15.77 billion.

Operating Cash Flow 20.13B
Capital Expenditures -4.37B
Free Cash Flow 15.77B
FCF Per Share 525.53
Full Cash Flow Statement

Margins

Gross margin is 43.23%, with operating and profit margins of 12.03% and -2.42%.

Gross Margin 43.23%
Operating Margin 12.03%
Pretax Margin 11.01%
Profit Margin -2.42%
EBITDA Margin 16.15%
EBIT Margin 12.03%
FCF Margin 12.16%

Dividends & Yields

This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.79%.

Dividend Per Share 35.00
Dividend Yield 0.79%
Dividend Growth (YoY) 100.00%
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -0.36%
Shareholder Yield 0.44%
Earnings Yield -2.37%
FCF Yield 11.92%
Dividend Details

Stock Splits

The last stock split was on May 17, 2024. It was a forward split with a ratio of 2.

Last Split Date May 17, 2024
Split Type Forward
Split Ratio 2

Scores

HYUNDAI BIOLAND has an Altman Z-Score of 5.53 and a Piotroski F-Score of 5.

Altman Z-Score 5.53
Piotroski F-Score 5